PHOENIX

凤凰城

,

，

March 12, 2026

2026年3月12日

/PRNewswire/ --

/PRNewswire/ --

Trinity Capital Inc.

三一资本公司

(Nasdaq:

（纳斯达克：

TRIN

三元

) (the 'Company'), a leading international alternative asset manager, today announced the commitment of $35 million in growth capital to

)（“公司”），一家领先的国际另类资产管理公司，今天宣布投入 3500 万美元的增长资本用于

Monteris Medical

蒙特里斯医疗

('Monteris'), a MedTech  company specializing in minimally invasive neurosurgical technology.

蒙特里斯（Monteris），一家专注于微创神经外科技术的医疗科技公司。

Monteris Medical develops and commercializes the NeuroBlate System, a robotically controlled laser interstitial thermal therapy (LITT) platform that uses MRI-guided laser technology to remove abnormal brain tissue. The system features robotic-controlled, precise, laser energy delivery that is used to treat brain tumors, radiation necrosis, and drug-resistant epilepsy.

Monteris Medical 开发并商业化了 NeuroBlate 系统，这是一种机器人控制的激光间质热疗 (LITT) 平台，利用 MRI 引导的激光技术去除异常脑组织。该系统具有机器人控制、精准的激光能量传递功能，用于治疗脑肿瘤、放射性坏死和耐药性癫痫。

The NeuroBlate system is designed to provide a minimally invasive alternative to traditional open neurosurgery, with the goal of helping patients experience lower complication rates and shorter hospital stays..

NeuroBlate 系统旨在为传统的开放性神经外科手术提供一种微创的替代方案，目标是帮助患者降低并发症发生率并缩短住院时间。

'We believe Monteris is advancing innovation across the life sciences sector with technology that is expanding treatment options in neurosurgery,' said Rob Lake, Senior Managing Director, Life Sciences at Trinity Capital. 'We are proud to support a team that is not only pushing the boundaries of medical technology, but also delivering meaningful new treatment options for patients.'.

“我们相信，Monteris 正在通过扩展神经外科治疗选择的技术推动生命科学领域的创新，”Trinity Capital 生命科学高级董事总经理 Rob Lake 表示。“我们很自豪能够支持一个不仅突破医疗技术界限，还为患者提供有意义的新治疗选择的团队。”

The growth capital will help support Monteris Medical's commercialization of the Neuroblate System and expansion of clinical research programs.

增长资本将有助于支持Monteris Medical公司Neuroblate系统的商业化以及临床研究项目的扩展。

'Securing this new credit facility from Trinity Capital, alongside the support of our Series E equity investors, strengthens our ability to accelerate growth and continue delivering innovative, minimally invasive neurosurgical solutions for patients in need,' said Martin J. Emerson, President and CEO of Monteris Medical.

“通过Trinity Capital获得这一新的信贷支持，加上我们E轮融资投资者的支持，增强了我们加速增长的能力，并继续为有需要的患者提供创新的、微创的神经外科解决方案，”Monteris Medical总裁兼首席执行官Martin J. Emerson表示。

'Trinity's partnership reflects strong confidence in our strategy, the NeuroBlate System, and the expanding clinical impact our technology is making across leading neuroscience centers. This financing ensures we can further invest in commercial expansion, product innovation, and the teams who bring our mission to life every day.'.

“Trinity的合作关系体现了对我们战略、NeuroBlate系统以及我们的技术在领先的神经科学中心不断扩大临床影响的强烈信心。这笔融资确保我们可以进一步投资于商业扩展、产品创新以及每天实现我们使命的团队。”

About Trinity Capital Inc.

关于三一资本公司

Trinity Capital Inc. (Nasdaq:

Trinity Capital Inc.（纳斯达克：

TRIN

三元

) is an international alternative asset manager that seeks to deliver consistent returns for investors through access to private credit markets. Trinity Capital sources and structures investments in well-capitalized growth-oriented companies across five distinct lending verticals: Sponsor Finance, Equipment Finance, Tech Lending, Asset Based Lending, and Life Sciences.

）是一家国际另类资产管理公司，通过进入私人信贷市场为投资者寻求稳定回报。Trinity Capital 在五个不同的借贷领域中寻找并构建对资本充足、成长导向型公司的投资：发起人融资、设备融资、科技贷款、资产抵押贷款和生命科学。

As a long-term, trusted partner for innovative companies seeking tailored debt solutions, Trinity Capital has deployed more than $5.5 billion across over 463 investments since inception in 2008 (as of December 31, 2025). Headquartered in Phoenix, Arizona, Trinity Capital's dedicated team is strategically located across the United States and Europe.

自2008年成立以来（截至2025年12月31日），作为寻求定制债务解决方案的创新型公司的长期可信赖合作伙伴，Trinity Capital已在463项投资中部署了超过55亿美元。Trinity Capital总部位于亚利桑那州凤凰城，其专业团队战略性地分布在美国和欧洲各地。

For more information on Trinity Capital, please visit .

有关三一资本的更多信息，请访问 。

trinitycapital.com

三一资本.com

and stay connected to the latest activity via LinkedIn and X (@trincapital).

通过 LinkedIn 和 X (@trincapital) 保持与最新动态的联系。

About Monteris and the NeuroBlate® System

关于Monteris和NeuroBlate®系统

Monteris Medical develops and markets innovative, MR‑guided laser ablation systems that enable minimally invasive, robotically controlled brain surgery, often referred to as laser ablation, LITT (laser interstitial thermal therapy) or SLA (stereotactic laser ablation). The company's NeuroBlate System is designed for adults and children aged two and older and uses laser technology to precisely destroy abnormal brain tissue, including certain brain tumors and specific areas of the brain that cause seizures due to epilepsy.

Monteris Medical 开发并销售创新的、磁共振引导的激光消融系统，该系统能够实现微创的、机器人控制的脑部手术，通常被称为激光消融、LITT（激光间质热疗）或 SLA（立体定向激光消融）。该公司的 NeuroBlate 系统适用于两岁及以上的成人和儿童，利用激光技术精确摧毁异常的脑组织，包括某些脑肿瘤和因癫痫引发癫痫发作的大脑特定区域。

NeuroBlate is the only LITT platform with a robotic interface that supports the targeted, safe delivery of laser energy and is supported by published prospective clinical data. Multicenter studies on NeuroBlate show that patients typically experience short hospital stays, low rates of complications, improved quality of life and outcomes comparable to open surgical resection..

NeuroBlate 是唯一一个拥有机器人界面的LITT平台，该平台支持靶向、安全地传递激光能量，并有已发表的前瞻性临床数据支持。关于NeuroBlate的多中心研究表明，患者通常住院时间短，并发症发生率低，生活质量得到改善，疗效与开放手术切除相当。

SOURCE Trinity Capital Inc.

来源：三一资本公司

21

21

%

%

more press release views with

更多新闻发布视图与

Request a Demo

请求演示